The pursuit of anti-inflammatory agents has led to intensive research on the inhibition of soluble epoxide hydrolase (sEH) and cytokine production using medicinal plants. In this study, we evaluated the efficacy of -khellactone, a compound isolated for the first time from the roots of . The compound was found to be a competitive inhibitor of sEH, exhibiting an IC value of 3.1 ± 2.5 µM and value of 3.5 µM. Molecular docking and dynamics simulations illustrated the binding pose of (-)-khellactone within the active site of sEH. The results suggest that binding of the inhibitor to the enzyme is largely dependent on the Trp336-Gln384 loop within the active site. Further, -khellactone was found to inhibit pro-inflammatory cytokines, including NO, iNOS, IL-1β, and IL-4. These findings affirm that -khellactone could serve as a natural therapeutic candidate for the treatment of inflammation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610198 | PMC |
http://dx.doi.org/10.3390/plants12203656 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!